Pharmacokinetics of TNO155 in Participants With Mild, Moderate, or Severe Hepatic Impairment Compared to Matched Healthy Participants

Clinical trial NCT05490030 · WITHDRAWN

Trial details

NCT number: NCT05490030
Sponsor: Novartis Pharmaceuticals
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Hepatic Impairment

Start date: 2025-03-06
Primary completion: 2025-06-26
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.